Dr Matthew Thomas Hendricks, OD | |
401 Phalen Blvd, Saint Paul, MN 55130-5302 | |
(651) 254-7500 | |
Not Available |
Full Name | Dr Matthew Thomas Hendricks |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 6 Years |
Location | 401 Phalen Blvd, Saint Paul, Minnesota |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104391325 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 3656 (Minnesota) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.
Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
› Verified 9 days ago
Provider Name | Group Health Plan Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.
Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
› Verified 9 days ago
Provider Name | Brokea Inc. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1346453735 PECOS PAC ID: 9537328075 Enrollment ID: O20120405000013 |
News Archive
Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.
Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Matthew Thomas Hendricks, OD 8170 33rd Ave S # Ms 21110q, Minneapolis, MN 55425-4516 Ph: () - | Dr Matthew Thomas Hendricks, OD 401 Phalen Blvd, Saint Paul, MN 55130-5302 Ph: (651) 254-7500 |
News Archive
Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.
Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
› Verified 9 days ago
Kennedy Eye Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1790 Lexington Ave N, Saint Paul, MN 55113 Phone: 651-488-6771 Fax: 651-488-5576 | |
Maggie Scott, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1360 University Ave W Ste 106, Saint Paul, MN 55104 Phone: 651-251-0317 | |
Dr. Julie M Blenker, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 261 Ruth St N Ste E, Saint Paul, MN 55119 Phone: 651-739-5173 Fax: 651-739-8907 | |
John Heyen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1020 Bandana Blvd W, Saint Paul, MN 55108 Phone: 651-241-7000 | |
Broecker Eye & Optical Optometrist Medicare: Medicare Enrolled Practice Location: 2356 University Ave W, Suite 260, Saint Paul, MN 55114 Phone: 651-645-8124 Fax: 651-645-8125 | |
Dr. David Andrew Spande, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1300 University Ave W, Optical Clinic, Saint Paul, MN 55104 Phone: 651-641-6181 Fax: 651-646-3292 |